Overview


Immunodermatology, a medical specialty that focuses on treating skin conditions characterized by immune system responses, is one of the most important medical specializations. The diagnosis and treatment for many diseases that affect the epithelial cells, including the skin, intestines, and respiratory tract, is made possible by immunohematology testing. The skin, which is the first organ to be deficient in the body, produces cytokines and fights against antigens from T cells. Skin diseases can affect anyone, from newborns to the elderly. They can be acute or chronic, genetic or conditional, painless or painful, and can also be severe or persistent. Immunodermatology, a medical specialty that focuses on treating skin conditions characterized by immune system responses, is the only medical specialty that specializes in this area. The diagnosis and treatment for many diseases that affect the epithelial cells, including the skin, intestines, and respiratory tract, is made possible by immunohematology testing. The skin, which is the first organ in the body that is defective, produces cytokines and fights T cells. Immunodermatology, a medical specialty, focuses on the diagnosis and treatment of skin conditions that are characterized by immune system responses. The diagnosis and treatment for many diseases that affect the epithelial cells, including the skin, mucous and intestines, and the respiratory tract, is made possible by immunohematology testing. The skin is the largest organ and most heavily in the body. Patients can develop skin diseases at any age, from newborns to old age. They can be either temporary or chronic, painful or not, conditional, genetic or both. The skin is the first organ in the body that has a defect. It produces cytokines and fights against antigens in T cells. The rise in elderly people may make skincare more important.

Immunodermatology examines skin to understand immunity. Several areas are being studied, including photo-immunology (effects of UV light on skin defense), allergic contact dermatitis, atopic eczema, and Hidradenitis supranuclear, as well as immunology of microbial skin diseases such as retrovirus infections, leprosy, and Hidradenitis. The immunomodulation of common immunological skin conditions is being treated with biologics that target the TNFalfa as well as the chemokine-receptor inhibitors. The study of immunodermatology, which includes skin, hair, and mucous membranes and is closely related to immunology, is a part of the overall understanding of human integument. Immunodermatology, a medical specialty, focuses on diagnosing and treating skin conditions that are caused by defective immune system responses. For the diagnosis and treatment, of many diseases that affect epithelial organs such as skin, mucous membranes, and respiratory tracts, immunohematology testing is crucial.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Immunodermatology Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Immunodermatology Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Novartis
  • Abbvie
  • Valeant Pharmaceuticals
  • Bausch Health
  • Glenmark Pharmaceuticals Inc.
  • Astellas Pharma
  • Novopharm Limited
  • Aspen Pharmacare Inc.
  • Prometheus Laboratories
  • Taro Pharmaceuticals Inc.
  • Nucare Pharmaceuticals Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Systemic sclerosis
  • Dermatomyositis
  • Psoriasis
  • Vitiligo
  • Alopecia areata
  • Lichen sclerosus
  • Allergic Dermatitis
  • Atopic Dermatitis
  • Lupus erythematosus
  • Blistering diseases
  • Connective tissue diseases

By Diagnosis

  • Immunofluorescence Testing
  • Direct
  • Indirect
  • Biopsy
  • Blood Test

By Therapy

  • Drug Therapy
  • Corticosteroids
  • Immunosuppressant
  • Calcineurin Inhibitors
  • TNF Alfa Inhibitors
  • Interleukin Inhibitors
  • Antibiotics
  • Intensed Pulsed Light (IPL)Therapy
  • Stem Cell Therapy
  • Gene Therapy

By Mode of Administration

  • Oral
  • Topical
  • Intrvenous

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Immunodermatology Market By Type, By Diagnosis, By Therapy, By Mode of Administration and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Immunodermatology Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Immunodermatology Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Immunodermatology Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Immunodermatology Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Systemic sclerosis
        2. Dermatomyositis
        3. Psoriasis
        4. Vitiligo
        5. Alopecia areata
        6. Lichen sclerosus
        7. Allergic Dermatitis
        8. Atopic Dermatitis
        9. Lupus erythematosus
        10. Blistering diseases
        11. Connective tissue diseases

  • 8.   Immunodermatology Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunofluorescence Testing
        2. Direct
        3. Indirect
        4. Biopsy
        5. Blood Test

  • 9.   Immunodermatology Market, By Therapy Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drug Therapy
        2. Corticosteroids
        3. Immunosuppressant
        4. Calcineurin Inhibitors
        5. TNF Alfa Inhibitors
        6. Interleukin Inhibitors
        7. Antibiotics
        8. Intensed Pulsed Light (IPL)Therapy
        9. Stem Cell Therapy
        10. Gene Therapy

  • 10.   Immunodermatology Market, By Mode of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Topical
        3. Intrvenous

  • 11.   North America Immunodermatology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Immunodermatology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Immunodermatology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Immunodermatology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Immunodermatology Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Novartis
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbvie
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Valeant Pharmaceuticals
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bausch Health
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Glenmark Pharmaceuticals Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Astellas Pharma
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Novopharm Limited .
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Aspen Pharmacare Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Prometheus Laboratories
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Taro Pharmaceuticals Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Nucare Pharmaceuticals Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients